What are the chances of a successful embryo transfer in a patient with endometriosis, who underwent excision surgery, followed by 3 months of Lupron (leuprolide) and letrozole for 90 days, and was treated with vaginal probiotics, sildenafil, 20mg of prednisone, and lovenox (enoxaparin) daily, with a 8mm endometrial lining, using PGT (preimplantation genetic testing) tested embryos, and considering the addition of metformin 1000mg, given a negative day 6 post-transfer home test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

I strongly recommend waiting for your official beta hCG blood test before making conclusions about the transfer, as home pregnancy tests at 6 days post-transfer can be unreliable. If this transfer fails, consider consulting with your reproductive endocrinologist about immune testing, ERA/EMMA/ALICE testing to check for endometrial receptivity and microbiome issues, or possibly additional embryo banking. Your current protocol is comprehensive - the endometriosis excision, Lupron suppression, letrozole treatment, and supportive medications (lovenox, prednisone, sildenafil) address many potential barriers to implantation, as supported by studies such as 1 which highlights the importance of hormonal treatments for endometriosis. Your 8mm lining is favorable, and using PGT-tested embryos increases success rates. For endometriosis patients with PGT-tested embryos and appropriate suppression therapy, success rates typically range from 40-60% per transfer, as indicated by the most recent and highest quality study available, although the exact success rate in your specific case may vary. The addition of metformin may help if you have insulin resistance or PCOS, but its effectiveness in your case would depend on individual factors. Some studies, such as 2, have explored the efficacy of letrozole combined with oral contraceptives in treating endometriosis-related pain, showing promising results, but the direct impact on implantation success rates is less clear. Other treatments like elagolix and leuprolide have also been evaluated for endometriosis-related pain management, with patient preferences playing a significant role in treatment choice, as seen in 3. Historically, letrozole has been studied for its potential in reducing endometriosis and associated pain, with early studies like 4 showing significant reduction in endometriosis and pain relief, although more recent studies like 5 suggest that its effectiveness compared to other treatments like OCP may not be significantly different. Remember that even with optimal conditions and tested embryos, implantation involves complex biological processes that aren't entirely controllable, and sometimes multiple transfers are needed before success. Key factors influencing your outcome include the effectiveness of your current protocol, the quality of your embryos, and your individual response to the treatments, including any potential benefits from the addition of metformin. Given the complexity of endometriosis and its treatment, a personalized approach, considering your specific health conditions, medical history, and the latest research findings, is crucial for maximizing your chances of a successful transfer.

References

Research

Hormonal treatments for endometriosis: The endocrine background.

Reviews in endocrine & metabolic disorders, 2022

Research

Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2021

Research

Effect of Letrozole on endometriosis-related pelvic pain.

Medical journal of the Islamic Republic of Iran, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.